Previous studies have shown that the transcriptional coactivator protein Gcn5/Ada4 functions as a catalytic histone acetyltransferase (HAT). In this work, we examine the roles of the Ada2 and Ada3 coactivator proteins which are functionally linked to Gcn5.
Introduction
In eukaryotes, DNA is packaged into chromatin by extensive interactions with histone proteins (1) . This repressive nature of chromatin can be relieved in the cell by chromatin remodeling and chromatin modifying activities which produce an altered chromatin structure accessible to and recognized by other components of the RNA polymerase II transcriptional machinery (2). Acetylation is a post-translational modification of special interest since the transcriptional activity of a gene strongly correlates with hyperacetylation of the N-terminal tails of histone proteins present in the chromatin template (3) . The molecular basis for this observation is suggested by findings that the transcriptional coactivator protein Gcn5 functions as a histone acetyltransferase (HAT)
[footnote 1] and that Gcn5 HAT activity correlates well with cellular Gcn5-mediated transcriptional activation (4) . In the yeast cell, Gcn5 is assembled into the 1.8 megadalton SAGA complex together with at least 12 other proteins from the ADA, SPT and TAFs (TBP-associated factors) families of transcriptional coactivators as well as the Tra1 protein (4) . SAGA not only acetylates the tails of histone proteins assembled into nucleosomes, but is also recruited to promoters by direct interactions with acidic activators and the general transcription factor, TBP (4) . These findings suggest that multisubunit HAT complexes such as SAGA might coordinate their HAT and coactivator functions to activate transcription in the cell.
The ADA genes were isolated in genetic screens for transcriptional adapters that interacted functionally with the VP16 acidic activation domain (5, 6) . These experiments identified the genes for Ada1, Ada2, Ada3, Ada4 and Ada5, the last two of which are Functions of Ada2 and Ada3 in histone acetylation identical to Gcn5 and Spt20 respectively (4) . All are components of the SAGA complex.
Functional interaction of Ada2, Ada3 and Gcn5 was suggested by additional genetic studies which established that mutations in Ada2, Ada3 or Gcn5 result in similar phenotypes, while deletions of two of the three genes did not cause a more severe phenotype than a single deletion (7, 8) . Two-hybrid and cotranslation experiments indicate that Ada2 interacts directly with Ada3 and Gcn5, while cotranslation experiments demonstrate the Ada2, Ada3 and Gcn5 proteins form a ternary complex which might represent a SAGA subcomplex (9) (10) (11) . It has been suggested that Ada2 contributes to SAGA's coactivator function by binding directly to VP16 and TBP (12, 13) .
Gcn5 is the catalytic subunit responsible for SAGA's HAT activity since Gcn5 on its own will acetylate histone tails (14, 15) , and since mutations in the Gcn5 HAT domain affect SAGA's HAT activity in vitro as well as promoter-directed histone acetylation and transcriptional activation in vivo (16) (17) (18) . However, while SAGA acetylates both naked and nucleosomal histones, Gcn5 appears to acetylate only naked histones efficiently (15) .
Since Gcn5 interacts with other proteins in the multisubunit SAGA complex, it is likely that other SAGA components interact with Gcn5 to modulate its HAT activity. Ada2 and Ada3 are candidates for such SAGA components for three reasons. Firstly, as discussed previously, Ada2, Ada3 and Gcn5 can form a ternary complex. Secondly, SAGA and a second yeast HAT complex called ADA share these three common subunits as well as the ability to acetylate nucleosomal histones (15) . Thirdly, the yeast HAT A2 complex, which has been shown to contain Ada2 and Gcn5 and is suspected to contain Ada3, was recently shown to acetylate nucleosomal histones in vitro (19) .
To analyze how SAGA components modulate the catalytic activity of Gcn5, we have reconstituted the yeast Ada2 and Ada3 transcriptional coactivator proteins with yeast Gcn5 in vivo using a newly developed polycistronic E. coli coexpression vector (20) .
Our results suggest that Ada2 with Ada3 are necessary and sufficient to form a HAT subcomplex with Gcn5 capable of acetylating histone tails in a chromatin template. 
Experimental Procedures Coexpression and purification of recombinant proteins
The Ada2, Ada3 and Gcn5 genes were amplified from yeast genomic DNA, cloned into cloning vectors and the entire coding regions verified by DNA sequencing. Each of the three genes was subcloned into the transfer cloning vector, pET3aTr (20) to create pET3aTr-Ada2, pET3aTr-Ada3 and pET3aTr-Gcn5. The Ada3 and Gcn5 genes were also subcloned into the pRET3a-HisTrxN fusion protein expression vector, a derivative of pRET3a (21) , so that the Ada3 and Gcn5 coding regions were positioned in frame with a 6xHis-thioredoxin-NIa recognition site fusion tag to create pRET3a-HisTrxNAda3 and pRET3a-HisTrxNGcn5 respectively. The first 51 nucleotides of the Gcn5 gene were recoded during this procedure to optimize codon usage and to remove the BamHI site near the 5' end of the Gcn5 gene. The transfer vectors were used to subclone the Ada2, Ada3 and Gcn5 translational cassettes into the pST37 polycistronic expression vector to create pST37-HisTrxNGcn5-yAda2, pST37-HisTrxNAda3-yAda2 and pST37-Ada3-Ada2-Gcn5. Expression of proteins and complexes were performed in BL21(DE3)pLysS cells using 0.2 mM IPTG (22) . The following expression conditions were used after optimizing temperature and length of induction to maximize recovery of soluble protein or complex: 4 hours at 37°C for Ada2, 6 hours at 28°C for HisTrxNAda3, 4 hours at 28°C for HisTrxNGcn5, 3 hours at 28°C for HisTrxGcn5/Ada2, 4 hours at 28°C for HisTrxNAda3/Ada2 and 12 hours at 18°C for Ada3/Ada2/Gcn5.
Gcn5 was prepared by purifying the fusion HisTrxNGcn5 from the soluble extract of Functions of Ada2 and Ada3 in histone acetylation cells by cobalt metal affinity chromatography (Talon resin, Clontech), cleaving the fusion tag specifically using TEV NIa protease (23) , and recovering the flow through from a second cobalt affinity chromatography to remove the fusion tag. A similar procedure was used to purify the Ada2/Gcn5 complex except that an additional Superdex S200-HR size exclusion chromatography step (Amersham-Pharmacia) was used after the second cobalt affinity column to remove excess Gcn5. Ada2 was purified from the insoluble fraction of the cell extract by Sephacryl S-300 size exclusion chromatography (AmershamPharmacia) of Triton X-100 washed inclusion bodies, followed by POROS HQ anionexchange and POROS HS cation-exchange chromatography (Applied Biosystems) with all three chromatography steps performed in 8 M urea. The fusion HisTrxNyAda3 was purified from the soluble extract of cells by cobalt metal affinity chromatography, and QSepharose anion-exchange chromatography (Amersham-Pharmacia). After NIa cleavage to remove the fusion tag, the yAda3 polypeptide was purified under denaturing conditions by Source Q anion-exchange (Amersham-Pharmacia) in urea followed by Vydac C4 reverse phase chromatography (using an acetonitrile gradient in 0.1% TFA).
The Ada2/Ada3/Gcn5 complex used in this work was expressed and purified as a nonfusion complex, but similar results are obtained when the HisTrxN tag is used for purification and removed by NIa cleavage. For nonfusion purification, the soluble extract of cells expressing the ternary complex was precipitated with 1.5 M ammonium sulfate, and the pellet fraction further purified by Q-Sepharose, Source Q and Source S chromatography (Amersham-Pharmacia).
Isolation of ADA complexes
Functions of Ada2 and Ada3 in histone acetylation Strains used for the purification of ADA complexes were BY4742 (MATα his3∆1 leu2∆0 lys2∆0 ura3∆0) and an ada3∆ derivative (MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ada3 ∆::KAN), from Research Genetics. ADA complex was partially purified from 4L of wildtype or ada3∆ mutant strains, grown to mid log phase in YPD media as described (15) .
Briefly, whole-cell extracts were prepared by glass bead disruption and bound to 5 ml of Nickel-NTA agarose (Qiagen). The resin was then washed in a column with 20 mM imidazole, followed by elution of the bound proteins with 300 mM imidazole. The Ni 2+ -NTA -agarose resin eluate was directly loaded onto a Mono Q HR 16/10 column (Amersham-Pharmacia). Bound proteins were eluted with a 500 ml linear gradient from 100 to 500 mM NaCl. Peak fractions containing the ADA complex were concentrated down to 0.5 ml using a Centriprep-30 concentrator (Millipore). Samples were then loaded on a Superose 6 HR 10/30 column (Amersham-Pharmacia) equilibrated with 350 mM NaCl. Peak ADA fractions were pooled and used in HAT assays and Western blotting.
HAT assays
HAT assays were performed as described previously (15) using core histones or oligonucleosomes isolated from chicken erythrocytes (24) . Lysine acetylation specificity was determined using synthetic peptides blocked at specific lysine residues by incorporating acetylated lysines at these positions (25) .
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Results
Recombinant complexes containing Ada2, Ada3 and Gcn5 by coexpression
We initially pursued overexpression in E. coli and purification of the individual Ada2 (50 kDa), Ada3 (79 kDa) and Gcn5 (51 kDa) polypeptides. Ada3 and Gcn5 were expressed as fusions to a cleavable N-terminal combination hexahistidine-thioredoxin tag, while Ada2 was expressed as a nonfusion polypeptide. Although we managed to express and purify Ada2 ( polypeptide is available in much smaller quantities, it appeared unlikely that we would obtain sufficient quantities of the Ada2/Ada3/Gcn5 complex for biophysical studies using To solve this problem of generating active complexes containing Ada2, Ada3 and Gcn5, we employed a novel polycistronic expression system developed in our laboratory to successfully coexpress Ada2, Ada3 and Gcn5 in various combinations in vivo. This expression system enables rapid construction of polycistronic expression plasmids capable of coexpressing up to 4 individual genes (20) . In particular, we have overexpressed the binary Ada2/Ada3 and Ada2/Gcn5 complexes, and the ternary Ada2/Ada3/Gcn5 complex each from single expression plasmids. Our unsuccessful attempts to overexpress and purify the yeast Ada3/Gcn5 complex suggest that Ada3 and Gcn5 do not form a stable complex on their own (data not shown), consistent with previously published results (10) . In contrast, the Ada2/Gcn5 complex remains intact over affinity, size-exclusion and anion-exchange chromatography (Fig 2a and data not shown). Furthermore, we find that coexpressed Ada2, Ada3 and Gcn5 copurify in a complex over both anion and cation ion-exchange chromatography (Fig. 2b) . The components of the Ada2/Ada3/Gcn5 complex also coelute by size-exclusion chromatography with an elution time consistent with a 434 ± 64 kDa complex assuming a globular shape (data not shown). If one copy of each protein is present in the complex, the 50 kDa Ada2, 79 kDa Ada3 and 51 kDa Gcn5 proteins would form a 180 kDa complex, suggesting that either the complex is significantly elongated or that a more complicated stoichiometry exists. We are able to isolate milligram quantities of nearly homogenous Ada2/Ada3/Gcn5 complex under nondenaturing conditions in this manner.
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HAT activity of Ada2/Gcn5 and Ada2/Ada3/Gcn5 complexes
We first compared the HAT activity of our recombinant Gcn5 to the Ada2/Ada3/Gcn5 complex normalized by the amount of Gcn5 present in a HAT fluorogram assay. We find that the Ada2/Ada3/Gcn5 complex acetylates histone H3 in naked histones significantly better than Gcn5 alone (Fig. 3a, lanes 2 and 3) . Furthermore, the Ada2/Ada3/Gcn5 complex possesses substantial nucleosomal HAT activity under conditions where an equivalent amount of Gcn5 does not acetylate nucleosomes to a detectable level (Fig. 3a , lanes 5 and 6). Thus, the presence of Ada2 and Ada3 increases Gcn5's HAT activity on core histones, and enables acetylation of nucleosomal histones.
To dissect the individual roles of Ada2 and Ada3 in histone acetylation, we next compared the HAT activity of Gcn5 alone, the Ada2/Ada3 and Ada2/Gcn5 binary complexes and the Ada2/Ada3/Gcn5 triple complex in a liquid HAT assay. The Ada2/Ada3 complex did not exhibit any HAT activity (data not shown), consistent with Gcn5 being the catalytic subunit of SAGA. We used an equivalent amount of Gcn5 in each of the remaining assays, as judged by Coomassie blue staining of an SDS-PAGE gel. Gcn5 displays moderate HAT activity towards naked histones, whereas the Ada2/Ada3/Gcn5 complex possesses four to five times higher activity (Fig. 3b) .
Significantly, the Ada2/Gcn5 binary complex exhibits essentially the same level of HAT activity as the Ada2/Ada3/Gcn5 triple complex. This suggests that Ada2 is sufficient to potentiate Gcn5's HAT activity with core histones.
Identical amounts of the same samples were assayed using a nucleosomal substrate again Functions of Ada2 and Ada3 in histone acetylation normalizing against the amount of Gcn5 except in the case of the Ada2/Ada3 complex.
We used nucleosomal arrays containing approximately 10 nucleosomes isolated from chicken erythrocytes, the same source of the naked histones. Consistent with most published results, we find that Gcn5 fails to acetylate nucleosomes to any significant degree above background (Fig. 3c) . We did not detect any HAT activity for the Ada2/Ada3 complex with nucleosomal substrates (data not shown), and the Ada2/Gcn5 complex was found to possess only modest nucleosomal HAT activity (Fig. 3c) .
However, the Ada2/Ada3/Gcn5 ternary complex acetylated nucleosomal substrates about 15x better than Ada2/Gcn5 and approximately 100x better than Gcn5 (Fig. 3c) . Similar results are obtained with the nucleosomal arrays used in Fig. 3 , and with mononucleosomes (data not shown). We have also compared the activities of these recombinant reagents with SAGA complex isolated from yeast cells. We detect comparable HAT activity for the SAGA complex and the Ada2/Ada3/Gcn5 complex using both core and nucleosomal histone substrates (data not shown).
Our HAT assays using samples which contain the same amount of Gcn5 assume that Gcn5 was equally active in each sample. However, it is formally possible that our failure to detect nucleosomal acetylation by Gcn5 results from a lower specific activity of our Gcn5 as compared to the Ada2/Ada3/Gcn5 complex. Therefore, we also compared the nucleosomal HAT activity of Gcn5 and the Ada2/Ada3/Gcn5 ternary complex when normalized by their respective core histone HAT activities. The fluorogram in Fig. 3a , lanes 7-12 shows that the Ada2/Ada3/Gcn5 complex still possesses significantly more nucleosomal HAT activity than the barely detectable acetylation produced by Gcn5 alone. Thus the failure to observe nucleosomal HAT activity of Gcn5 is not due to a lower specific activity of a Gcn5 preparation, but rather that the presence of Ada2 and Ada3 confers upon Gcn5 the ability to efficiently acetylate histones in a nucleosomal substrate. In addition to their different abilities to acetylate nucleosome, Gcn5 protein and the SAGA complex also display distinct specificities towards the lysine residues in the Nterminal tail of histone H3. Gcn5 shows a marked preference for Lys14 of H3, with only background acetylation at the other available lysine residues at position 9, 18 and 23 (25, 26) . In contrast, the SAGA complex will acetylate an expanded set of lysine residues, preferring Lys18, 14, 9 and 23 in decreasing order of preference (25) . The acetylation specificity of the SAGA complex was determined using H3 N-terminal peptides synthesized with acetylated lysines blocking all but single positions at Lys 9, 14, 18 and 23. The use of these blocked synthetic peptides were previously validated in experiments which produced essentially the same results as antibodies which recognize site-specific acetylated histone tails and microsequencing of radiolabeled histones (25) .
We have used the same synthetic H3 peptides to examine the lysine specificity of the binary Ada2/Gcn5 and the ternary Ada2/Ada3/Gcn5 complexes, and compared these results to those from parallel experiments using Gcn5 and the SAGA complex. The results of these experiments are shown in Fig. 4 . Our results for Gcn5 and SAGA are very similar to those reported previously. However, we find that that Ada2/Gcn5 complex has acquired the ability to acetylated Lys18, although it still maintains a 4-5 fold preference for Lys14. In contrast, the Ada2/Ada3/Gcn5 complex displays the same trend observed for the entire SAGA complex of Lys18 > Lys14 > Lys9 > Lys23. In this assay, we observe the overall acetylation for the Ada2/Ada3/Gcn5 complex to be greater 
Ada3 is required for nucleosomal HAT activity in fractionated yeast extracts
Our result that the presence of Ada2 enhances the core histone HAT activity of Gcn5 is consistent with the finding that the core histone HAT activity of SAGA complex isolated from yeast cells lacking Ada2 is greatly reduced (27) . We sought similar confirmation for the physiological role of Ada3 protein by isolating SAGA and ADA complexes from yeast cells deleted for Ada3. We find that the SAGA complex is disrupted by deletion of Ada3, indicating that Ada3 may play an important role in maintaining the structural integrity of SAGA (data not shown). In contrast, an apparent ADA complex complex containing Ada2 and Gcn5 was isolated from yeast cells lacking Ada3. This complex elutes from MonoQ anion-exchange resin under similar conditions as the ADA complex, and elutes from Superose size exclusion resin with a slightly smaller apparent molecular weight than the ADA complex (data not shown). This apparent Ada3 deficient ADA complex is reduced in H3-specific core histone activity and nearly devoid of H3-specific nucleosomal HAT activity compared to the intact ADA complex when normalized by Gcn5 content (Fig 5) . These results suggest that Ada3 plays an important role in the structural integrity of the SAGA complex and further that Ada3 is required for Gcn5-mediated nucleosomal HAT activity in yeast extracts. (28, 29) . The individual subunits would be highly unlikely to fold on their own since hydrophobic residues in the interior of the heteromeric complex would be exposed in the individual subunit. Coexpression allows the component polypeptides to fold together in a cellular environment in the presence of protein folding machinery such as chaperones. We have used a modular, polycistronic expression system to coexpress various combinations of Ada2, Ada3 and Gcn5 to generate both binary and ternary complexes of these polypeptides under soluble conditions. It is interesting to note that the Ada2 polypeptide, which apparently could only be expressed on its own in inclusion bodies, was mostly soluble when coexpressed with Ada3 and Gcn5, albeit at lower overall expression levels.
We find that Ada2/Ada3/Gcn5 is the minimal complex which acetylates nucleosomal histones and matches the H3 lysine specificity of the SAGA HAT complex. We propose that the Ada2/Ada3/Gcn5 complex is a catalytic subcomplex of both the ADA and SAGA complexes for the following reasons. Firstly, both ADA and SAGA contain Ada2, Ada3 and Gcn5 (15) , and our results here confirm previously published reports based on twohybrid and coimmunoprecipitation studies that Ada2, Ada3 and Gcn5 form a ternary (10, 11) . Secondly, both ADA and SAGA complexes acetylate H3 tails preferentially, with only weak acetylation observed for H2B (15) . The same preference is detected for the Ada2/Ada3/Gcn5 complex (Fig. 4 and data not shown) . Thirdly, the Ada2/Ada3/Gcn5 complex acetylates nucleosomal histones as do both the ADA and SAGA complexes (15) . Finally, both ADA and SAGA complexes display similar H3 lysine specificities observed for the Ada2/Ada3/Gcn5 complex (25) .
The roles of Ada2 and Ada3 in histone acetylation are also supported by the behavior of HAT complexes isolated from yeast strains deleted for either Ada2 or Ada3. In contrast to Ada2, deletion of Ada3 results in the disruption of the SAGA complex, which prevents us from analyzing the HAT activity of an Ada3-deficient SAGA complex. We do detect an apparent Ada3-deficient ADA complex which possesses less core histone and greatly reduced nucleosomal HAT activity. The reduced core histone activity of this Ada3-less ADA complex was somewhat unexpected since the complex still contains both Ada2 and Gcn5, whereas recombinant Ada2/Gcn5 complex had similar core histone HAT activity to the recombinant Ada2/Ada3/Gcn5 complex. However, it is difficult to make a direct comparison between these results since the ADA complex contains additional factors which may modulate the HAT activity of the Ada2/Ada3/Gcn5 subcomplex. (31) . Secondly, our results indicate that Ada3 is required for nucleosomal HAT activity and lysine specificity, which suggests that Ada3 might be involved in recognizing histone tails in a nucleosome context. It is interesting to note that the two histone tails targeted by SAGA, H3 and H2B, are the only two histone tails that emerge between the gyres of the DNA superhelix in the nucleosome core particle structure (32) . It is possible that Ada3 alone or in combination with Ada2 and/or Gcn5 might recognize histone tails emerging from between the DNA gyres. A different explanation is that Ada3 might be required to access the histone tails if the tails make additional interactions with the DNA (33), although such interactions were not observed in the nucleosome core particle crystal structure (32).
These roles for Ada2 and Ada3 in organizing a complex with Gcn5 which affects Gcn5's catalytic activity are substantially different from suggestions, based on experiments using the individual proteins, that both Ada2 and Ada3 may directly mediate interactions with activators (10, 13) . Although the results in this report do not exclude such potential Ada2/Gcn5, Ada2/Ada3/Gcn5 and SAGA were incubated with the wild-type peptide (WT), the peptide with no acetylation sites available (0) or with peptides with only single acetylation sites available (9, 14, 18, 23) . The histogram shows scintillation counts from liquid HAT assays normalized to the activity obtained using the WT peptide as described previously (25) . 
